NOVABRIDGE
Live / Allowed — Published for opposition (as of 06 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99434741
- Mark type
- Word mark
- Filed
- 09 Oct 2025
- Published for opposition
- 06 Oct 2026
- Attorney of record
- Jacqueline Lesser
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for treatment of cancer, vascular diseases, neurological diseases and disorders, and cardiovascular diseases and disorders, biological preparations for treatment of cancer, vascular diseases, neurological diseases and disorders, and cardiovascular diseases and disorders, biologics in the nature of cells for medical use, antibodies for medical purposes, tumor suppressing agents.
Owner
- I-MAB Biopharma US Limited, Rockville, MD, US
- I-MAB Biopharma US Limited, Rockville, MD, US
Prosecution history
- 06 Oct 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Oct 2026 — PUBLISHED FOR OPPOSITION
- 30 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 May 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 20 May 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 26 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Feb 2026 — NON-FINAL ACTION E-MAILED
- 26 Feb 2026 — NON-FINAL ACTION WRITTEN
- 26 Feb 2026 — ASSIGNED TO EXAMINER
- 01 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED